Potential mechanism of phytochemical-induced apoptosis in human prostate adenocarcinoma cells: Therapeutic synergy in genistein and β-lapachone combination treatment

Cancer Cell International

Volumn 4, Issue , 2004, Pages

  Kumi Diaka, James ^a   Saddler Shawnette, Simone ^a   Aller, Alex ^b   Brown, Jayann ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BETA LAPACHONE; CASPASE 3; CASPASE 3 INHIBITOR; DEATH RECEPTOR; DICOUMAROL; GENISTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TREATMENT PLANNING;

EID: 18144381225     PISSN: 14752867     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2867-4-5     Document Type: Article

References (40)

1. Lynn AG, Ries MS: Stat Bite: Top 5 cancers for females and males in the U.S. JNCI 1995, 87:867.
2. Zhau HE, Pisters LL, Hall MC, Zhao LS, Troncoso P, Pollack A, Chung LWK: Biomarkers associated with prostate cancer progression. J Cell Biochem Suppl 1994, 19:208-216.
3. Webber MM, Waghray A, Bello D: Prostate-specific antigen, a serine protease, facilitates human prostate cancer cell invasion. Clin Cancer Res 1995, 1:1089-1094.
4. Umekita Y, Hiipakka RA, Kokontis JM, Liao S: Human prostate tumor growth in athymic mice: Inhibition by androgens and stimulation by finasteride. Proc Natl Acad Sci USA 1996, 93:11802-11807.
5. Kumi-Diaka J, Nguyen V, Butler A: Cytotoxic potential of the phytochemical genistein isoflavone (4′,5′,7-trihydroxyisoflavone) and certain environmental compounds on testicular cell lines. Biol Cell 1999, 91:515-523.
6. Kumi-Diaka J: Chemosensitivity of human prostate cancer cells PC3 and LNCaP to genistein isoflavone and β-lapachone. Biol Cell 2002, 94:37-44.
7. Liu X, Kim CN, Yang J, Jemmerson R, Wang X: Induction of apoptotic program in cell-free extracts requirement for dATP and cytochrome c. Cell 1996, 86:147-157.
8. Green Dr, Reed JC: Mitochondria and apoptosis. Science 1998, 281:1309-1312.
9. Janicke RU, Ng P, Sprengart ML, Porter AG: Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J Biol Chem 1998, 273:15540-15545.
10. You-Zhi Li, Chiang Li J, Pinto AV, Pardee AB: Release of mitochondrial cytochrome C in both apoptosis and necrosis induced by b-Lapachone in human carcinoma cells. Molecular Medicine 1999, 5:232-239.
11. Nicholson DW, Thornburry NA: Life and Death Decision. Science 2003, 299(5604):214-215.
12. Li CJ, Wang C, Pardee AB: Induction of apoptosis by β-lapachone in human prostate cancer cells. Cancer Res 1995, 55:3712-3715.
13. Li CJ, Li YZ, Pinto AV, Pardee AB: Potent inhibition of tumor survival in vivo by β-Lapachone plus Taxol: combining drugs imposes different artificial checkpoints. Proc Natl Acad Sci USA 1999, 96:133-69.
14. Adlercreutz CH, Goldin BR, Gorbach SL, Hockerstedt KA, Watanabe S, Hamalainen EK, Markkanen MH, Makela TH, Wahala KT: Soybean phytoestrogen intake and cancer risks. J Nutr 1995, 125:757S-770S.
15. Kim H, Peterson TG, Barnes S: Mechanism of action of the soy isoflavone, genistein: Emerging role for its effects via transforming growth factor signaling pathways. Am J Clin Nutr 1998, 68(Suppl):1418S-1425S.
16. Dixon RA, Daneel Ferreira: Genistein. Phytochemistry 2002, 60:205-211.
17. 2-M. Cancer Res 1993, 53:1328-1331.
18. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987, 262:5592-5595.
19. Messina MJ, Persky V, Setchell KDR, Barnes S: Soy intake and cancer risk: A review of the in vitro and in vivo data. Nutr Cancer 1994, 21:113-131.
20. Mousavi Y, Adlercreutz H: Genistein is an effective stimulator of sex hormone binding globulin production in hepatocellular human liver cancer cells and suppresses proliferation of these cells in culture. Steroids 1993, 58:301-304.
21. Planchon SM, Wuerzberger S, Frydman B, Witiak DT, Hutson P, Church DR, Wilding G, Boothman DA: β-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response. Cancer Res 1995, 55:3706-3711.
22. Wuerzberger SM, Pink JJ, Planchon SM, Byers KL, Bornmann WG, Boothman DA: Induction of apoptosis in MCF-7WS8 breast cancer cells by beta-lapachone. Cancer Res 1998, 58:1876-1885.
23. Robertson N, Haigh A, Adams GE, Stratford IJ: Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphorase activity and hypoxia Eur. Evr J Cancer 1994, 30A:1013-1019.
24. Cadenas E: Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem Pharmacol 1995, 49(2):127-140.
25. Ross D, Beall H, Traver RD, Siegel D, Phillips RM, Gibson NW: Bioactivation of quinones by DT-diaphorase, molecular, biochemical, and chemical studies. Oncol Res 1994, 6:493-500.
26. Pink JJ, Wuerzberger-Davis S, Tagliarino C, Planchon SM, Xiao He Yang, Froelich CJ, Booth DA: Activation of a cysteine protease in MCF-7 and T47D breast cancer cells during β-lapachone-mediated apoptosis. Exp Cell Res 2000, 255:144-155.
27. Pink JJ, Planchon SM, Tagliarino C, Varnes ME, Siegel D, Boothman DA: NAD(P)H:quinone oxidoreductase activity is the principal determinant of β-lapachone cytotoxicity. J Biol Chem 2000, 275(8):5416-5424.
28. Boothman DA, Trask DK, Pardee AB: Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase I. Cancer Res 1989, 49(3):605-612.
29. Boorstein RJ, Pardee AB: β-Lapachone greatly enhances MMS lethality to human fibroblasts. Biochem Biophys Res Commun 1984, 118:828-834.
30. Li CJ, Zhang LJ, Dezube BJ, Crumpacker CS, Pardee AB: Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci USA 1993, 90:1839-1842.
31. Li CJ, Averboukh L, Pardee AB: β-lapachone; a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin. J Biol Chem 1993, 268:22463.
32. Frydman B, Marton LJ, Sun JS: Induction of DNA topoisomerase II-mediated DNA cleavage by β-lapachone and related naphthoquinones. Cancer Res 1997, 57:620-626.
33. Kip1) and Bak in the β-lapachone-induced apoptosis of human prostate cancer cells. Mol Pharmacol 2001, 59:784.
34. Planchon SM, Pink JJ, Tagliarino C, Bornman WG, Varnes ME, Boothman DA: β-Lapachone-induced apoptosis in human prostate cancer cells: Involvement of NQO1/xip3 Experimental Cell Research. 2001, 267(1):95-06.
35. Zhang G, Guru V, Kain SR, Yan G: Early detection of apoptosis using a fluorescent conjugate of annexin V. Bio Techniques 1997, 23:525-531.
36. Cotter TG, Martin SJ: Techniques in apoptosis; a user's guide. Portland Press Ltd London; 1994:10-12.
37. Kumi-Diaka J, Rodriguez R, Gaudazi G: Influence of Genistein (4′,5′,7-trihydroxyiso-flavone) on the growth and proliferation of selected testicular cells. Biology of the Cell 1998, 90:349-354.
38. Kumi-Diaka J, Butler A: Caspase-protease activation during the process of genistein-induced apoptosis in TM4 testicular cells. Biol Cell 2000, 92:115-124.
39. Kumi-Diaka J, Sanderson AA, Hall A: The mediating role of caspase-3 protease in the intracellular mechanism of genistein-induced apoptosis in human prostatic carcinoma cell lines, DU145 and LNCaP. Biology of the Cell 2000, 92:595-604.
40. Tagliarino C, Pink JJ, Reinicke KE, Simmers SM, Wuerzberger-Davis SM, Boothman DA: Mucalpain activation in β-Lapachone-mediated apoptosis. Cancer Biol Ther 2003, 2(2):153-154.